Scientific article
English

Recombinant Antibodies for Academia: A Practical Approach

Published in

Chimia, vol. 70, no. 12, p. 893-897

Publication date

2016

Abstract

After several decades of optimization, phage display technology enables the routine isolation and production of recombinant monoclonal antibodies in vitro. As such it has the potential to provide the academic community with a vast, inexpensive and renewable supply of well-characterized reagents, reducing bottlenecks in basic science, helping increase reproducibility of experiments, and phasing out the use of animals for production and discovery of antibodies. Yet the overwhelming majority of fundamental research laboratories still use incompletely characterized antibodies developed in animals. In order to promote increased use of recombinant antibodies in academia, we have recently initiated an open source recombinant antibody facility in Geneva (http://www.unige.ch/antibodies). Here we describe our experience at the Geneva Antibody Facility: the various techniques involved in isolation and production of antibodies, the strategic choices that we have made, and what we hope will be a bright future for this project as part of a growing movement in the scientific community to replace all animal-derived antibodies with recombinant antibodies.

Citation (ISO format)

COSSON, Pierre, HARTLEY, Oliver. Recombinant Antibodies for Academia: A Practical Approach. In: Chimia, 2016, vol. 70, n° 12, p. 893–897. doi: 10.2533/chimia.2016.893

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0009-4293
487views
5downloads

Technical informations

Creation

31/08/2017 12:51:00

First validation

31/08/2017 12:51:00

Update

08/01/2025 10:30:44

Status update

08/01/2025 10:30:44

Last indexation

08/01/2025 10:32:58
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated